SC 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

(Rule 13d-102)

Under the Securities Exchange Act of 1934

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13D-1(B), (C), AND (D) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2
(Amendment No.     )*

Advancis Pharmaceutical Corporation

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)

00764L109

(CUSIP Number)

April 9, 2007

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)

x Rule 13d-1(c)

o Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 00764L109
	1.	Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). TANG CAPITAL PARTNERS, LP
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		o
		(b)		x
	3.	SEC Use Only
	4.	Citizenship or Place of Organization DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With			5.		Sole Voting Power 0
			6.		Shared Voting Power 3,325,000
			7.		Sole Dispositive Power 0
			8.		Shared Dispositive Power 3,325,000
	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,325,000
	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
	11.	Percent of Class Represented by Amount in Row (9) 6.9%
	12.	Type of Reporting Person (See Instructions) PN

2

CUSIP No. 00764L109
	1.	Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). TANG CAPITAL MANAGEMENT, LLC
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		o
		(b)		x
	3.	SEC Use Only
	4.	Citizenship or Place of Organization DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With			5.		Sole Voting Power 0
			6.		Shared Voting Power 3,325,000
			7.		Sole Dispositive Power 0
			8.		Shared Dispositive Power 3,325,000
	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,325,000
	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
	11.	Percent of Class Represented by Amount in Row (9) 6.9%
	12.	Type of Reporting Person (See Instructions) OO

3

CUSIP No. 00764L109
	1.	Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). KEVIN C. TANG
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		o
		(b)		x
	3.	SEC Use Only
	4.	Citizenship or Place of Organization UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With			5.		Sole Voting Power 0
			6.		Shared Voting Power 3,325,000
			7.		Sole Dispositive Power 0
			8.		Shared Dispositive Power 3,325,000
	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 3,325,000
	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
	11.	Percent of Class Represented by Amount in Row (9) 6.9%
	12.	Type of Reporting Person (See Instructions) IN

4

Item 1.
	(a)	Name of Issuer Advancis Pharmaceutical Corporation, a Delaware corporation (the “Issuer”)
	(b)	Address of Issuer’s Principal Executive Offices 20425 Seneca Meadows Parkway, Germantown, MD 20876
Item 2.
	(a)	Name of Person Filing This Statement on Schedule 13G (this “Statement”) is filed by Tang Capital Partners, LP (“Tang Capital Partners”); Tang Capital Management, LLC, the general partner of Tang Capital Partners (“Tang Capital Management”); and Kevin C. Tang, the manager of Tang Capital Management.
	(b)	Address of Principal Business Office or, if none, Residence 4401 Eastgate Mall, San Diego, CA 92121
	(c)	Citizenship Tang Capital Partners is a Delaware limited partnership. Tang Capital Management is a Delaware limited liability company. Mr. Tang is a United States citizen.
	(d)	Title of Class of Securities Common Stock, $0.01 par value per share (the “Common Stock”)
	(e)	CUSIP Number 00764L109
Item 3.	If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
	(a)	o	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
	(b)	o	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
	(c)	o	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
	(d)	o	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
	(e)	o	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
	(f)	o	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
	(g)	o	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
	(h)	o	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
	(i)	o	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
	(j)	o	Group, in accordance with §240.13d-1(b)(1)(ii)(J).
	Not applicable.

5

Item 4.	Ownership
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
	(a)	Amount beneficially owned:    Tang Capital Partners.  Tang Capital Partners is the record and beneficial owner of 1,900,000 shares of Common Stock.  Tang Capital Partners also holds a warrant to purchase 1,425,000 shares of Common Stock at an exercise price of $2.27 per share (subject to adjustment as set forth in the warrant).  Tang Capital Partners shares voting power and dispositive power over such shares and warrants with Tang Capital Management and Kevin C. Tang. Tang Capital Management. Tang Capital Management, as the general partner of Tang Capital Partners, may be deemed to beneficially own the 1,900,000 shares held of record by Tang Capital Partners and the warrant to purchase 1,425,000 shares of Common Stock at an exercise price of $2.27 per share (subject to adjustment as set forth in the warrant). Tang Capital Management shares voting and dispositive power over such shares and warrants with Tang Capital Partners and Kevin C. Tang. Kevin C. Tang.  Kevin C. Tang, as Manager of Tang Capital Management, may be deemed to beneficially own the 1,900,000 shares held of record by Tang Capital Partners and the warrant to purchase 1,425,000 shares of Common Stock at an exercise price of $2.27 per share (subject to adjustment as set forth in the warrant).  Mr. Tang shares voting and dispositive power over such shares with Tang Capital Partners and Tang Capital Management.  Mr. Tang disclaims beneficial ownership of all shares reported herein except to the extent of his pecuniary interest therein.
	(b)	Percent of class:

Tang Capital Partners	6.9	%
Tang Capital Management	6.9	%
Kevin C. Tang	6.9	%

(c)	Number of shares as to which the person has:
	(i)	Sole power to vote or to direct the vote

Tang Capital Partners	0 shares
Tang Capital Management	0 shares
Kevin C. Tang	0 shares

(ii) Shared power to vote or to direct the vote    

Tang Capital Partners	3,325,000 shares
Tang Capital Management	3,325,000 shares
Kevin C. Tang	3,325,000 shares

(iii) Sole power to dispose or to direct the disposition of   

Tang Capital Partners	0 shares
Tang Capital Management	0 shares
Kevin C. Tang	0 shares

(iv) Shared power to dispose or to direct the disposition of   

Tang Capital Partners	3,325,000 shares
Tang Capital Management	3,325,000 shares
Kevin C. Tang	3,325,000 shares

Item 5.	Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   o.
Item 6.	Ownership of More than Five Percent on Behalf of Another Person
	Not applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
	Not applicable.
Item 8.	Identification and Classification of Members of the Group
	Not applicable.

6

Item 9.	Notice of Dissolution of Group
	Not applicable.
Item 10.	Certification
	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

7

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date:		April 19, 2007
TANG CAPITAL PARTNERS, LP
By: Tang Capital Management, LLC, its General Partner
By:	/s/ Kevin C. Tang
	Kevin C. Tang, Manager
TANG CAPITAL MANAGEMENT, LLC
By:	/s/ Kevin C. Tang
	Kevin C. Tang, Manager
/s/ Kevin C. Tang
Kevin C. Tang

8

EX-99.1

Exhibit 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, $0.01 par value, of Advancis Pharmaceutical Corporation and further agree to the filing of this agreement as an exhibit thereto.  In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G.

Date: April 19, 2007	TANG CAPITAL PARTNERS, LP,
	By:	Tang Capital Management, LLC
	Its:	General Partner
	By:	/s/ Kevin C. Tang
		Name: Kevin C. Tang
		Title:   Manager
	TANG CAPITAL MANAGEMENT, LLC
	By:	/s/ Kevin C. Tang
		Name: Kevin C. Tang
		Title:   Manager
	/s/ Kevin C. Tang
	Name: Kevin C. Tang